We describe the occurrence of a giant squamous cell carcinoma in a patient receiving vemurafenib for the treatment of late melanoma mestastases. Although the development of keratoacanthomas and squamous cell carcinomas (SCC) has been described during vemurafenib therapy, most of the reported cases are treated with surgical excision. In the present case, SCC regressed after drug withdrawal.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.3109/15569527.2014.949345 | DOI Listing |
Publication Analysis
Top Keywords
squamous cell
8
virologic genetic
4
genetic evaluation
4
evaluation vemurafenib-induced
4
vemurafenib-induced skin
4
skin cancers
4
cancers describe
4
describe occurrence
4
occurrence giant
4
giant squamous
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!